Kewaunee Scientific (NASDAQ:KEQU) Stock Crosses Below Two Hundred Day Moving Average - Time to Sell?

Key Points

• Kewaunee Scientific stock fell below its 200-day moving average, trading as low as $35.46 versus the 200‑day MA of $39.06 and last at $36.11 on light volume, a common technical warning sign for investors.
• Analyst sentiment is neutral: Weiss Ratings reiterated a "Hold" and MarketBeat reports an average rating of "Hold" (only one analyst rating published).
• Small‑cap fundamentals and ownership: the company has a market cap of about $104 million and a P/E of 9.7, with institutional investors owning roughly 32.7% of the shares.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $39.06 and traded as low as $35.46. Kewaunee Scientific shares last traded at $36.11, with a volume of 2,436 shares traded.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a "hold (c)" rating on shares of Kewaunee Scientific in a report on Thursday, April 2nd. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of "Hold".

Kewaunee Scientific Price Performance

The firm has a 50-day simple moving average of $37.31 and a 200-day simple moving average of $39.06. The firm has a market cap of $103.64 million, a P/E ratio of 9.71 and a beta of 0.67. The company has a current ratio of 2.12, a quick ratio of 1.45 and a debt-to-equity ratio of 0.58.

Hedge Funds Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KEQU. Bank of America Corp DE raised its holdings in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after purchasing an additional 443 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in Kewaunee Scientific in the third quarter valued at $38,000. US Bancorp DE boosted its holdings in Kewaunee Scientific by 80.0% in the third quarter. US Bancorp DE now owns 900 shares of the technology company's stock valued at $38,000 after purchasing an additional 400 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Kewaunee Scientific during the 2nd quarter worth about $60,000. Finally, Barclays PLC purchased a new position in shares of Kewaunee Scientific during the 4th quarter valued at about $92,000. Hedge funds and other institutional investors own 32.69% of the company's stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation NASDAQ: KEQU is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.